Journal Article Summary
The article discusses a clinical trial aimed at evaluating the effectiveness of amlodipine, a calcium channel blocker, in treating subcortical ischemic vascular dementia (SIVD), which is a common form of vascular dementia. This condition affects millions globally and currently lacks approved pharmacological treatments. The study is significant as it seeks to provide evidence for a potential new treatment option for SIVD, addressing a critical gap in care for patients suffering from this debilitating condition.
The trial, named AFFECT, is a multi-center, double-blind, placebo-controlled study involving 588 participants aged 50 and older diagnosed with SIVD. Participants will be randomly assigned to receive either amlodipine or a placebo for a duration of 52 weeks, with assessments conducted at various intervals to measure cognitive function and other health outcomes. The primary measure of effectiveness will be the change in cognitive scores on the Vascular Dementia Assessment Scale (VADAS-cog) after 12 months, alongside several secondary outcomes related to cognitive and functional abilities, quality of life, and caregiver burden.
While the study is promising, it has limitations, including the potential for participant dropout and the challenge of ensuring accurate data collection. Patients should be aware that participation in clinical trials may involve risks, including side effects from the medication. It is essential for individuals considering participation or those affected by SIVD to discuss their options with healthcare professionals, who can provide guidance on the suitability of clinical trials and alternative treatment strategies.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Greenan Caroline, Murphy Lynn, Yu Ly-Mee, Kehoe Patrick G., Coulthard Elizabeth, Bath Philip, Stewart Robert, Jones Rob, et al.. A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol. Trials 2016. DOI: 10.1186/s13063-016-1449-3. PMID: 27430267. PMCID: PMC4950108.
Featured Pill Pals Product
Amlodipine 10 mg Tablets --- 30 Count --- Ascend Pharma Labs --- Generic For Norvasc
Amlodipine 10 mg Tablets — 30 Count — Ascend Pharma Labs — Generic For Norvasc is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
